Search CROs

• Clinical Operations
• Clinical Trial Services
• Data Management & eClinical

Curavit is an innovation CRO specializing in decentralized and virtual clinical trials, offering a comprehensive suite of CRO services from study design through FDA submission with a proprietary Virtual Clinical Site platform.

• Biostatistics & Statistical Programming
• Clinical Operations
• Clinical Trial Services

BioBoston CRO delivers flexible clinical research consulting across regulatory affairs, medical writing, biostatistics, clinical data management, quality assurance, and project management for biotechnology and pharmaceutical sponsors.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Citeline provides clinical trial intelligence, planning, feasibility, patient engagement, and regulatory compliance solutions to pharmaceutical sponsors. The platform delivers benchmarking across 400k+ trials, site selection, protocol optimization, and disclosure management services.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Sacura specializes in clinical trial management and regulatory support for biotech and pharma companies, with expertise in complex international studies and late-stage preclinical-to-market development planning.

• Bioanalysis
• Biostatistics & Statistical Programming
• Clinical Operations

Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

• Clinical Trial Services
• Regulatory Affairs
• US FDA Regulatory Strategy

Dermatology-focused CRO providing integrated, turnkey solutions across non-clinical, clinical, and regulatory development from concept to commercialization.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.